Min Yuan Selected Research

sang ju yin

1/2022

Effects of Modified Sang ju-Yin Decoction Combined with IFNαlb Nebulization on IL-1β and HBD2 in Children with Asthmatic Bronchitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Min Yuan Research Topics

Disease

56	Neoplasms (Cancer) 01/2024 - 11/2003
9	Infections 02/2024 - 10/2009
8	Carcinogenesis 06/2023 - 11/2013
7	Neoplasm Metastasis (Metastasis) 01/2022 - 01/2004
7	Breast Neoplasms (Breast Cancer) 01/2022 - 12/2011
5	Inflammation (Inflammations) 04/2024 - 01/2019
5	Lung Neoplasms (Lung Cancer) 01/2022 - 05/2016
5	Fibrosis (Cirrhosis) 01/2022 - 04/2012
4	Lung Injury 01/2024 - 01/2020
4	Testicular Neoplasms (Testicular Cancer) 01/2022 - 02/2018
4	Proteinuria 01/2018 - 04/2013
3	Glioma (Gliomas) 04/2024 - 11/2003
3	Obesity 03/2024 - 12/2019
3	Colorectal Neoplasms (Colorectal Cancer) 09/2023 - 01/2017
3	Schistosomiasis (Bilharziasis) 06/2023 - 10/2012
3	Hypertension (High Blood Pressure) 05/2023 - 01/2021
3	Immune System Diseases (Immune Disorders) 03/2023 - 06/2020
3	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 01/2008
3	Alzheimer Disease (Alzheimer's Disease) 01/2022 - 05/2016
3	Acute Lung Injury 11/2021 - 01/2020
3	Hypoxia (Hypoxemia) 10/2021 - 05/2010
3	Rheumatoid Arthritis 08/2021 - 01/2017
3	Starvation 01/2020 - 01/2018
3	Squamous Cell Carcinoma (Epidermoid Carcinoma) 09/2019 - 11/2003
3	Multiple Myeloma 02/2016 - 10/2012
2	Insulin Resistance 03/2024 - 01/2021
2	Drug-Related Side Effects and Adverse Reactions 02/2024 - 01/2023
2	Ulcerative Colitis 01/2024 - 01/2020
2	Reperfusion Injury 12/2023 - 01/2018
2	Postpartum Hemorrhage 02/2023 - 02/2022
2	Mesothelioma 01/2023 - 06/2020
2	Liver Failure 08/2022 - 12/2014
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 05/2022 - 01/2020
2	Chronic Hepatitis B 01/2022 - 11/2014
2	Triple Negative Breast Neoplasms 01/2022 - 01/2021
2	Body Weight (Weight, Body) 11/2021 - 01/2021
2	Necrosis 11/2021 - 01/2020
2	Glucose Intolerance 01/2021 - 11/2018
2	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 01/2021
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 10/2020 - 04/2010
2	Fibrosarcoma 06/2020 - 09/2007
2	Hepatocellular Carcinoma (Hepatoma) 03/2020 - 01/2018

Drug/Important Bio-Agent (IBA)

20	Proteins (Proteins, Gene)FDA Link 11/2023 - 04/2012
8	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2023 - 09/2007
6	Therapeutic UsesIBA 01/2023 - 04/2013
6	MicroRNAs (MicroRNA)IBA 01/2019 - 07/2015
5	AntibodiesIBA 01/2021 - 12/2011
4	Biomarkers (Surrogate Marker)IBA 04/2024 - 04/2012
4	FructoseIBA 03/2024 - 12/2019
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2023 - 01/2019
4	salicylhydroxamic acid (SHAM)IBA 01/2023 - 01/2018
4	CytokinesIBA 01/2022 - 01/2019
4	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 02/2018
4	Phosphotransferases (Kinase)IBA 01/2022 - 11/2003
4	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 11/2018
4	LipidsIBA 01/2020 - 01/2017
4	NucleotidesIBA 01/2020 - 01/2016
3	AntigensIBA 12/2023 - 10/2012
3	Mechanistic Target of Rapamycin Complex 1IBA 11/2023 - 10/2017
3	Dihematoporphyrin Ether (Porfimer Sodium)FDA Link 01/2023 - 09/2007
3	Small Interfering RNA (siRNA)IBA 07/2022 - 09/2018
3	anlotinibIBA 07/2022 - 01/2021
3	Triglycerides (Triacylglycerol)IBA 12/2021 - 11/2017
3	Phospholipids (Phosphatides)FDA LinkGeneric 01/2021 - 03/2017
3	Photosensitizing Agents (Photosensitizers)IBA 01/2021 - 04/2012
3	Oxygen (Dioxygen)IBA 06/2020 - 06/2011
3	CollagenIBA 01/2019 - 02/2009
3	ErbB Receptors (EGF Receptor)IBA 06/2017 - 11/2003
3	Messenger RNA (mRNA)IBA 12/2016 - 04/2010
2	BerberineIBA 04/2024 - 01/2020
2	ChemokinesIBA 04/2024 - 05/2016
2	LipopolysaccharidesIBA 01/2024 - 11/2021
2	AcidsIBA 01/2024 - 01/2022
2	Angiotensin IIIBA 01/2024 - 11/2021
2	Long Noncoding RNAIBA 05/2023 - 01/2017
2	SolutionsIBA 01/2022 - 01/2021
2	InflammasomesIBA 01/2022 - 01/2020
2	Adenosine Triphosphate (ATP)IBA 01/2022 - 01/2020
2	NitrogenIBA 01/2022 - 01/2016
2	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2021
2	Chimeric Antigen ReceptorsIBA 10/2021 - 01/2021
2	Interleukin-6 (Interleukin 6)IBA 08/2021 - 01/2021
2	Interleukin-2 (IL2)IBA 01/2021 - 01/2015
2	Peptides (Polypeptides)IBA 01/2021 - 01/2019
2	apatinibIBA 01/2021 - 01/2021
2	Amino Acids FDA Link 01/2021 - 11/2015
2	Blood Glucose (Blood Sugar)IBA 01/2021 - 01/2012
2	Interleukin-10 (Interleukin 10)IBA 01/2021 - 08/2015
2	IsotopesIBA 07/2020 - 11/2015
2	EnzymesIBA 01/2020 - 11/2017
2	Connexin 43 (Connexin43)IBA 09/2019 - 02/2018

Therapy/Procedure

21	Therapeutics 01/2023 - 01/2004
7	Photochemotherapy (Photodynamic Therapy) 01/2023 - 09/2007
5	Drug Therapy (Chemotherapy) 01/2022 - 12/2017
3	Immunotherapy 01/2024 - 01/2020
3	Blood Transfusion (Blood Transfusions) 02/2023 - 06/2020
3	Aftercare (After-Treatment) 01/2022 - 01/2021
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2024 - 04/2013
2	Radiofrequency Ablation 01/2022 - 03/2020
2	Cell- and Tissue-Based Therapy (Cell Therapy) 10/2021 - 01/2021